SCHEMBL8767045

SCHEMBL8767045

CC(C)OC(CC(=O)[O-])C[N+](C)(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
CYP1A2 P05177 1/20 0.62
HRH1 P35367 1/20 0.62
CYP2C19 P33261 2/20 0.59
RECQL P46063 1/20 0.59
SLC25A20 O43772 3/20 0.54
TP53 P04637 2/20 0.54
CYP2D6 P10635 2/20 0.54
TSHR P16473 2/20 0.54
SLC6A5 Q9Y345 2/20 0.54
KDM4E B2RXH2 1/20 0.54
CYP3A4 P08684 1/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
NFKB1 P19838 1/20 0.54
THPO P40225 1/20 0.54
HIF1A Q16665 1/20 0.54
HSD17B10 Q99714 1/20 0.54
SLC22A16 Q86VW1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26797580 1.00 MEN1 (0.62) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL26797583 1.00 MEN1 (0.62) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL1208087 0.92 MEN1 (0.71) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL4256715 0.92 MEN1 (0.71) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL17629809 0.92 MEN1 (0.71) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL1830071 0.84 MEN1 (0.57) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL25099744 0.82 LMNA (0.59) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL22056511 0.82 CYP1A2 (0.46) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL13210313 0.82 LMNA (0.59) MEN1KMT2ACYP1A2HRH1CYP2C19
SCHEMBL26797560 0.82 CYP1A2 (0.46) MEN1KMT2ACYP1A2HRH1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037354-B2 Cyclic pantetheine derivatives and uses thereof VECTIVBIO COMET AG (CH) 2024-07-16 US disclosed
US-20230348506-A1 MACROCYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC. (CH) 2023-11-02 US disclosed
CN-101179954-A Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses NUTRICIA NV (NL) 2008-05-14 CN disclosed
EP-0559625-B1 Esters of L-carnitine and acyl L-carnitine endowed with muscle relaxant activityselective on gastrointestinal tract and pharmaceutical compositions containing same SIGMA TAU IND FARMACEUTI (IT) 1997-08-27 EP disclosed
CN-1128139-A Hair-growing agent TANABE SEIYAKU CO (JP) 1996-08-07 CN disclosed
US-4551477-A ANTILIPEMIC AGENTS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1985-11-05 US disclosed
US-4439438-A ANTIDEPRESSANTS, INOTROPIC AGENTS CAVAZZA CLAUDIO (IT) 1984-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12037354-B2 Cyclic pantetheine derivatives and uses thereof VNN1, VKORC1, PANK3 MEN1 1478/4885KMT2A 4756/4885CYP1A2 503/4885
US-20230348506-A1 MACROCYCLIC PANTETHEINE DERIVATIVES AND USES THEREOF VNN1, VKORC1, VKORC1L1 MEN1 584/4885KMT2A 4677/4885CYP1A2 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.